Investigation of Approval Trends and Benefits of New Fixed-Dose Combination Drugs in Japan-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Investigation of Approval Trends and Benefits of New Fixed-Dose Combination Drugs in Japan

Published:2019-01-28 Issue: Volume: Page:216847901882191
ISSN:2168-4790
Container-title:Therapeutic Innovation & Regulatory Science
language:en
Short-container-title:Drug Inf J

Author:

Kikuchi Chikara¹^ORCID,Ohno Mifuyu¹,Izumo Takafumi²,Takahashi Satoru³,Aoki Masayuki⁴,Shimomura Hitoshi¹⁵,Kawano Yohei¹,Shimada Shuji¹,Aoyama Takao¹

Affiliation:

1. Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Chiba, Japan

2. Department of Pharmacy, Chiba-Nishi General Hospital, Matsudo, Chiba, Japan

3. Department of Pharmacy, Tokushukai General Incorporated Association, Chiyoda-ku, Tokyo, Japan

4. Department of Pharmacy, AIN Pharmacy Chiba-Nishi, Matsudo, Chiba, Japan

5. Department of Pharmacy, International University of Health and Welfare Ichikawa Hospital, Ichikawa, Chiba, Japan

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Public Health, Environmental and Occupational Health,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Link

http://journals.sagepub.com/doi/pdf/10.1177/2168479018821919

Reference35 articles.

1. Evaluation of the Efficacy and Tolerability of Fixed-Dose Combination Therapy of Azilsartan and Amlodipine Besylate in Japanese Patients With Grade I to II Essential Hypertension

2. Evaluation of the Efficacy and Tolerability of Combination Therapy With Candesartan Cilexetil and Amlodipine Besilate Compared With Candesartan Cilexetil Monotherapy and Amlodipine Besilate Monotherapy in Japanese Patients With Mild-to-Moderate Essential Hypertension: A Multicenter, 12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study

3. Combination Angiotensin Receptor Blocker/Hydrochlorothiazide as Initial Therapy in the Treatment of Patients With Severe Hypertension

4. Antihypertensive Efficacy and Tolerability of Two Fixed-Dose Combinations of Valsartan and Hydrochlorothiazide Compared with Valsartan Monotherapy in Patients with Stage 2 or 3 Systolic Hypertension: An 8-Week, Randomized, Double-Blind, Parallel-Group Trial

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3